skip to content
ESTABLISHED RELATIONSHIPS WITH 12 OF THE TOP 20 BIG PHARMA.

Custom Synthesis

Small Molecules

  • Design and development of synthesis routes for Active Pharmaceutical Ingredients (APIs), Advanced Intermediates and Regulatory Starting Materials (RSMs).
  • Seamless process scale-up from kilo lab to commercial scale driven by a Quality by Design (QbD) approach.
  • Proven expertise in complex chemistries, multi- step synthesis, green chemistry implementation through flow chemistry, biocatalysis, photochemistry, all underpinned by rigorous safety protocols.
  • We follow a multi-layered safety strategy encompassing process safety, powder safety, and electrostatic safety assessments, supported by extensive risk evaluations and a layers-of- protection approach.
  • Divi’s advanced particle engineering capabilities, including milling and micronization, enable precise particle size distribution. Our expertise also extends to the controlled generation and handling of polymorphs, ensuring optimal performance, stability, and bioavailability of pharmaceutical compounds.

Highly Potent APIs (HPAPIs)

  • Purpose built specialized containment facilities for the safe handling of high-potency compounds, including OEB-4 (OEL >1 to <10 μgm³) and OEB-5 (OEL>0.1 to <1 μg/m³) categories.
  • We offer development-to-commercial scale synthesis under strict cGMP conditions, backed by a strong track record in regulatory compliance and occupational safety.
  • Dedicated infrastructure for oncology and other potent APIs.
  • Safe and compliant handling of low Occupational Exposure Limit (OEL) compounds across all operational scales—including synthesis labs, analytical labs, warehousing, dispensing, manufacturing, and effluent treatment.
  • Comprehensive analytical and regulatory support from development to market

Peptides

  • Scalable production of linear, modified, and cyclic peptides using SPPS, LPPS and hybrid technologies.
  • cGMP compliant manufacturing for both clinical and commercial supply.
  • Supply of custom peptide fragments ranging from dipeptides, tripeptides, and tetrapeptides to longer sequences (up to 14-mer), ideal for use as regulatory starting materials and advanced intermediates.
  • We offer custom synthesis for a wide range of peptide building blocks—including protected amino acids (amino acid derivatives), protecting agents, resins, side chains, linkers, condensing agents, coupling agents, and TAGS—supported by complete backward integration.
  • Detailed analytical characterization for quality assurance and release testing.

Biological Buffers

  • Custom synthesis of biological buffers including MOPS, TRIS, HEPES, HEPPS/EPPS, PIPES, MES, TES, TAPS, BICINE, TAPSO, and Tricine to support biopharmaceutical and API manufacturing & formulations.
  • Our cGMP-grade production ensures consistent quality across batches, with scalable supply offerings from development to commercial volumes.
  • Complete documentation and regulatory support for global compliance